Application Notes & Case Studies

  1. Enhance Access And Improve Retention In Rare Disease Trials With HTS 4/17/2025

    Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.

  2. Accelerating Early Phase Oncology Study Development 4/17/2025

    Explore a close collaboration to co-develop a comprehensive, adaptive protocol designed to support key decisions across multiple trial phases for an innovative cancer therapy.

  3. Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study 4/17/2025

    This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.

  4. Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer 4/16/2025

    This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.

  5. Pioneering The End-To-End Decentralized Trial Experience 4/16/2025

    This collaboration highlights the potential of decentralized clinical trials (DCTs) to transform trial execution, as well as offering a replicable model for future research.

  6. Accelerate Your Oncology Breakthroughs 4/16/2025

    Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.

  7. Digital Outcome Measures Approved As Primary Endpoint In Cardiopulmonary Study 4/15/2025

    Discover how a clinical development program was saved using objective, continuous digital outcome measures.

  8. Faster Trial Planning and Site Selection 4/15/2025

    Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.

  9. Ergomed's Solutions To The Challenges of Oncology Trials 4/15/2025

    Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

  10. Strategic Pre-IND Consulting For Gene Therapy In Rare Leukemia 4/11/2025

    Learn about the collaborative efforts of an innovative biotech startup and Ergomed Consulting to overcome challenges in the pre-IND phase for a novel gene therapy targeting a rare form of leukemia.